Your browser doesn't support javascript.
loading
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.
Yoshino, T; Arnold, D; Taniguchi, H; Pentheroudakis, G; Yamazaki, K; Xu, R-H; Kim, T W; Ismail, F; Tan, I B; Yeh, K-H; Grothey, A; Zhang, S; Ahn, J B; Mastura, M Y; Chong, D; Chen, L-T; Kopetz, S; Eguchi-Nakajima, T; Ebi, H; Ohtsu, A; Cervantes, A; Muro, K; Tabernero, J; Minami, H; Ciardiello, F; Douillard, J-Y.
Afiliação
  • Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Arnold D; CUF Hospitals Cancer Centre, Lisbon, Portugal.
  • Taniguchi H; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Pentheroudakis G; Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
  • Yamazaki K; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Xu RH; Department of Medical Oncology, Sun Yat-Sen University (SYSU) Cancer Center, Guangzhou, China.
  • Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Ismail F; Department of Radiotherapy & Oncology, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia.
  • Tan IB; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
  • Yeh KH; Department of Oncology, National Taiwan University Hospital, and Cancer Research Center, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Grothey A; Division of Medical Oncology, Mayo Clinic Cancer Center, Rochester, USA.
  • Zhang S; Cancer Institute, Zhejiang University, Hangzhou, China.
  • Ahn JB; Division of Oncology, Department of Internal Medicine, Yonsei Cancer Center, Seoul, Korea.
  • Mastura MY; Pantai Cancer Institute, Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
  • Chong D; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
  • Chen LT; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
  • Kopetz S; Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Centre, Houston, USA.
  • Eguchi-Nakajima T; Department of Clinical Oncology, School of Medicine, St. Marianna University, Kanagawa, Japan.
  • Ebi H; Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Ohtsu A; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Cervantes A; CIBERONC, Department of Medical Oncology, Institute of Health Research, INCLIVIA, University of Valencia, Valencia, Spain.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Tabernero J; Medical Oncology Department, Vall d' Hebron University Hospital, Vall d'Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain.
  • Minami H; Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan.
  • Ciardiello F; Division of Medical Oncology, Seconda Università di Napoli, Naples, Italy.
  • Douillard JY; ESMO, Viganello-Lugano, Switzerland.
Ann Oncol ; 29(1): 44-70, 2018 01 01.
Article em En | MEDLINE | ID: mdl-29155929

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Colorretais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Colorretais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão